CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 44 filers reported holding CHEMBIO DIAGNOSTICS INC in Q4 2021. The put-call ratio across all filers is 5.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $23,617 | +0.6% | 53,409 | -50.0% | 0.00% | – |
| Q4 2022 | $23,468 | +23.5% | 106,818 | +100.0% | 0.00% | – |
| Q3 2022 | $19,000 | -45.7% | 53,409 | 0.0% | 0.00% | – |
| Q2 2022 | $35,000 | -16.7% | 53,409 | +4.9% | 0.00% | – |
| Q1 2022 | $42,000 | -27.6% | 50,909 | 0.0% | 0.00% | – |
| Q4 2021 | $58,000 | -54.3% | 50,909 | 0.0% | 0.00% | – |
| Q3 2021 | $127,000 | -53.6% | 50,909 | -44.7% | 0.00% | – |
| Q2 2021 | $274,000 | -72.7% | 92,109 | -67.8% | 0.00% | – |
| Q1 2021 | $1,003,000 | -16.3% | 285,880 | +13.3% | 0.00% | – |
| Q4 2020 | $1,199,000 | -2.9% | 252,380 | -0.7% | 0.00% | – |
| Q3 2020 | $1,235,000 | +112.9% | 254,106 | +42.3% | 0.00% | – |
| Q2 2020 | $580,000 | – | 178,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 354,670 | $887,000 | 0.55% |
| Newbridge Financial Services Group, Inc. | 61,675 | $154,000 | 0.10% |
| GAGNON SECURITIES LLC | 47,793 | $119,000 | 0.02% |
| Phocas Financial Corp. | 30,000 | $75,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 491,453 | $1,229,000 | 0.01% |
| SEGALL BRYANT & HAMILL, LLC | 701,318 | $1,754,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 179,680 | $449,000 | 0.01% |
| Jump Financial, LLC | 37,900 | $95,000 | 0.01% |
| Cutler Group LLC / CA | 44,918 | $112,000 | 0.01% |
| Virtu Financial LLC | 19,653 | $49,000 | 0.00% |